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ABSTRACT Antigenic peptides bound to class II major histocompatibility complex (MHC) proteins play a key role in the
distinction between “self” and “nonself” by the cellular immune system. Although the formation and dissociation of these
complexes are often thought of in terms of the simple mechanism MHC  PºMHC-P, studies of MHC-peptide dissociation
kinetics suggest that multiple interconverting forms of the bound MHC-peptide complex can be formed. However, the precise
relationship between observed dissociation data and proposed multiple-complex mechanisms has not been systematically
examined. Here we provide a mathematical analysis to fill this gap and attempt to clarify the kinetic behavior that is expected
to result from the proposed mechanisms. We also examine multiple-complex dynamics that can be “hidden” in conventional
experiments. Although we focus on MHC-peptide interactions, the analysis provided here is fully general and applies to any
ligand-receptor system having two distinct bound states.
INTRODUCTION
Proteins of the class II major histocompatibility complex
(MHC) are expressed on the surface of antigen-presenting
cells, where they display peptide fragments to receptors on
CD4 T helper cells. Like antibodies, these T-cell receptors
(TCRs) exhibit great diversity at their recognition site
(Davis and Bjorkman, 1988; Davis, 1990; Garboczi et al.,
1996; Garcia et al., 1996; Jardetzky, 1997), enabling them
to distinguish between different peptides in the context of
the MHC protein, effecting the specific cellular immune
response (reviewed in Abbas et al., 1994). It is generally
assumed that the immunologically active form of an MHC-
peptide complex adopts a single unique structure that can be
recognized by the TCR. However, a growing body of evi-
dence suggests that multiple isomeric complexes can be
formed in MHC-peptide systems (Dornmair et al., 1989;
Sadegh-Nasseri and McConnell, 1989; Beeson and McCon-
nell, 1994; Beeson et al., 1996; Schmitt et al., 1998a,b). In
several cases, these isomeric complexes can be distin-
guished by T cells (Viner et al., 1996; Rabinowitz et al.,
1997).
The structural changes involved in the formation of iso-
meric complexes are not well understood. Although the
static structures of several MHC-peptide complexes from
mice as well as humans have been characterized by x-ray
crystallography (Brown et al., 1993; Fremont et al., 1996,
1998; Jardetzky et al., 1996; Scott et al., 1998), such struc-
tures provide little information about the dynamics of the
complexes. Rather than rely upon structural data alone, this
laboratory has investigated MHC-peptide isomers indirectly
by studying the kinetics of formation and dissociation of
MHC-peptide complexes. Kinetic experiments have been
instrumental in elucidating the mechanism of MHC-peptide
binding (Fig. 1 A), which is thought to involve numerous
reactions. Initially present complexes of MHC with endog-
enous peptides (MPe) can dissociate to form empty MHC
(M) (Witt and McConnell, 1991, 1992). This “active” un-
bound MHC can reversibly convert to a “dormant” form
(MI) (Rabinowitz et al., 1998; Natarajan et al., 1999) or be
irreversibly inactivated (forming MX) (Mason and McCon-
nell, 1994). We shall not discuss these steps in detail here.
In studies of binding to labeled peptides (P*), it has been
shown in several cases that MHC can form multiple iso-
meric complexes ({MP*}1 and {MP*}2) (Sadegh-Nasseri
and McConnell, 1989; Witt and McConnell, 1992; Sadegh-
Nasseri et al., 1994). Reactions of these complexes, partic-
ularly interconversion and dissociation, will be the focus of
our discussion. Additional reactions not shown in Fig. 1
have also been proposed, for example, the displacement of
one peptide by another via a transient two-peptide interme-
diate (Tampe´ and McConnell, 1991; de Kroon and McCon-
nell, 1993, 1994; Witt and McConnell, 1994). We will not
discuss these ancillary reactions further, restricting our dis-
cussion to the subset of reactions shown in Fig. 1 B.
To assess the biological significance of isomeric MHC-
peptide complexes, it is important to know how and under
what conditions the different isomers are formed. If one
isomer is formed in vanishingly small amounts, or if the two
complexes interconvert very rapidly, the complexes might
not be distinguished by T cells. However, if isomeric MHC-
peptide complexes interconvert slowly, they might give rise
to distinct immune responses because of the short (10 s)
duration of MHC-peptide/TCR interactions under physio-
logical conditions (Matsui et al., 1991, 1994). This could be
particularly important if different MHC-peptide isomers are
preferentially formed in different in vivo environments. To
address these issues, it is necessary to solve the biophysical
problem of determining the proportions of the isomeric
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complexes that are present under various conditions, as well
as the rates at which they form and interconvert.
Unfortunately, the MHC-peptide system presents a num-
ber of obstacles to conventional kinetic analysis. Side reac-
tions of the empty MHC molecule and formation of empty
MHC by the dissociation of prebound endogenous peptides
make it difficult to interpret measurements of the binding
rates and equilibrium binding constants of labeled peptides.
Consequently, in the analysis presented here we restrict our
discussion to MHC-peptide dissociation reactions (Fig. 1
B). Although multiple forms of peptide-MHC complexes
are known (Boniface et al., 1996; Dadaglio et al., 1997;
Runnels et al., 1996), isomeric complexes of the labeled
MHC-peptide complex are not directly observed in kinetic
experiments, so the relative concentrations of these com-
plexes are generally unknown. The absence of well-defined
initial conditions greatly complicates the analysis of kinetic
data from MHC-peptide reactions (Steinfeld et al., 1989).
The relationships between the observed dissociation rate
constants and the microscopic rate constants are compli-
cated for all but the simplest cases. To illustrate our analysis
of MHC-peptide dissociation kinetics, we shall discuss ki-
netic data for a simulated two-complex MHC-peptide sys-
tem with arbitrarily chosen microscopic rate constants. In
addition, we will briefly apply the analysis to previously
published kinetic experiments to demonstrate the applica-
tion of this analysis to real experimental data. Although we
present our discussion in terms of MHC-peptide interac-
tions, the analysis provided here is fully general and applies
to dissociation studies of any ligand-receptor system having
two kinetically distinct bound states.
EXPERIMENTAL TECHNIQUES
Preparation and dissociation of
MHC-peptide complexes
The preparation of MHC-peptide complexes involves incubating MHC
proteins with an excess of peptide that is labeled with a radioactive tag
(Sadegh-Nasseri et al., 1994), a fluorescent moiety (Tampe´ and McCon-
nell, 1991; Witt and McConnell, 1994), or some other detectable group
(Jensen, 1992). This incubation is typically carried out under quasiphysi-
ological conditions of pH 5.3, 150 mM sodium chloride, and 37°C, to
mimic the conditions under which MHC loading occurs within the endo-
somal compartments of antigen-presenting cells (Tulp et al., 1994). After
a period of incubation, which generally lasts 10–20 h, the complex formed
is separated from unbound peptide, using a size exclusion column (Witt
and McConnell, 1991; de Kroon and McConnell, 1993). Samples of the
incubation mixture may be taken at various time points during the course
of the binding reaction; the amount of labeled peptide bound to the MHC
can then be measured to provide a profile of the binding kinetics (Witt and
McConnell, 1991; de Kroon and McConnell, 1993; Liang et al., 1995).
In a dissociation experiment, labeled MHC-peptide complex is prepared
and isolated as described above. The complex is then incubated under the
dissociation conditions of interest, which may or may not be the same as
the binding conditions. The amount of labeled complex is then measured
over time as the labeled peptide dissociates from the MHC. An unlabeled
competitor peptide is sometimes added to the incubation to inhibit rebind-
ing of dissociated peptide. The collected data are normalized and fit to
either a mono- or biexponential decay curve (Witt and McConnell, 1994),
as illustrated by Eqs. 1 and 2:
MP*t	
MP*0
 e
koff
o t (1)
MP*t	
MP*0
 Foe
kfast
o t Soe
kslow
o t (2)
The superscript o indicates the observed kinetic parameters. For the bipha-
sic curve, the magnitudes of the fast and slow exponential phases are
denoted by Fo and So, respectively. For the biphasic dissociation curve,
Fo  So  1. Such a dissociation curve is shown in Fig. 2.
Numerical simulations of experimental data
Dissociation curves and other experimental data for the hypothetical MHC-
peptide system discussed in this paper were generated by the numerical
evaluation of rate equations. Differential equations describing the rates of
reaction for the species shown in Fig. 1 A were integrated numerically
using Mathematica 3.0 (Wolfram Research) to determine the concentra-
tions of the species as functions of time. Magnitudes of the fast and slow
exponential phases of dissociation were taken from fits of the biexponential
equation (Eq. 2) to the simulated dissociation data. Except as otherwise
noted, values for the rate constants and initial concentrations were taken
from previous kinetic simulations (Beeson et al., 1996; Rabinowitz et al.,
1998). Rate constants: dissociation of endogenous peptide, ke  2 h

1;
reversible inactivation of MHC, kai  15 h

1; activation of dormant MHC,
kia  0.25 h

1; irreversible inactivation of MHC, kx  0.05 h

1; formation
of {MP*}1, kon,1  360 M

1 h
1; dissociation of {MP*}1, koff,1  0.7
h
1; conversion of {MP*}1 to {MP*}2, k12  0.48 h

1; conversion of
FIGURE 1 Dynamics of the peptide-MHC system. (A) Reactions that
have been inferred from kinetics experiments to occur in MHC-peptide
interaction. The species involved are M, “active” unbound MHC; P*,
labeled peptide; MI, “dormant” inactive MHC; MX, permanently inacti-
vated MHC; {MPe}, MHC bound to endogenous peptide; {MP*Pe}, ter-
nary complex of labeled and endogenous peptides with MHC; {MP*}1 and
{MP*}2, isomeric forms of the labeled peptide-MHC complex. (B) The
subset of reactions involved in the dissociation of the MHC-peptide
complexes.
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{MP*}2 to {MP*}1, k21  0.048 h

1; formation of {MP*}2, kon,2  61.7
M
1 h
1; dissociation of {MP*}2, koff,2  0.012 h

1. Initial concentra-
tions used for simulation of binding reactions: endogenous complex,
[{MPe}]0  1 M; all other MHC species  0; labeled peptide, [P*]0 
100 M. For dissociation reactions, the initial concentration of labeled
peptide was set at zero, and the initial concentration of unlabeled compet-
itor peptide was set at 100 M.
RESULTS AND DISCUSSION
Ambiguous dissociation kinetics
Fig. 2 shows a simulated dissociation curve for a complex of
MHC with peptide P*. The distinct biexponential shape of
the curve is not consistent with the simple reaction MP*3
M  P*. Two distinct MHC-peptide complexes must be
involved in the dissociation, as illustrated by Fig. 1 B
(Sadegh-Nasseri and McConnell, 1989). If the two com-
plexes were distinguishable by spectroscopic or other
means, their individual concentrations could be measured
over time to provide a complete picture of the kinetics of the
system (Fig. 3). However, for kinetic studies of MHC-
peptide systems, isomeric complexes of the MHC-peptide
complex generally appear as a single signal (see Experi-
mental Techniques), providing no information about the
individual concentrations of the complexes. As a conse-
quence, many different MHC-peptide systems with dispar-
ate microscopic behaviors could give rise to the same ob-
served dissociation curve (Fig. 3).
There are four microscopic rate constants involved in the
dissociation of a two-complex MHC-peptide system (Fig. 1
B), yet there are only two macroscopic rate constants ob-
served (Fig. 2). Without concentration data, there are two
degrees of freedom in the “solution space” of systems that
are consistent with our observed dissociation curve (Fig. 4).
We want to determine where our system lies in this solution
space. That is, we wish to know the microscopic kinetic
FIGURE 2 A typical biphasic dissociation curve for the simulated
MHC-peptide system discussed in the text. The time dependence of the
total concentration of complex is fit by [{MP*}]/[{MP*}]0  0.18e

1.2t 
0.82e
0.04t. The observed parameters are the magnitude of fast phase, Fo
0.18; the rate constant of the fast phase, kfast
o  1.2 h
1; and the rate
constant of the slow phase, kslow
o  0.04 h
1.
FIGURE 3 Many different two-complex MHC-peptides produce the ob-
served dissociation curve shown in Fig. 2. Shown are dissociation curves
for (A) Scheme 1, (B) Scheme 2, (C) Scheme 3, and (D) Scheme 4,
discussed in the text. The behavior of Scheme 5 is very similar to that of
B. Dashed lines indicate the concentrations of complexes {MP*}1 (– – –)
and {MP*}2 (— - —); the total concentration of complex is indicated by
the solid line. Note that although the behavior of the individual complexes
differs from one reaction scheme to another, the observed total concentra-
tion is identical for all of them.
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parameters (rate constants and initial concentrations) of the
system that produced the dissociation curve shown in Fig. 2.
Before addressing this issue, we shall first examine several
“candidate” systems that are consistent with these dissoci-
ation data.
The parallel system
One candidate is the “parallel” system, with two noninter-
converting complexes with the dissociation rate constants
and initial populations shown in Scheme 1.
MP*1
18%	
L|;
0
0 MP*2
82%	
1.2 h
1n ,0.04 h
1
M P*
Scheme 1
As shown, the rate of interconversion between the com-
plexes in this system is negligible. This system produces the
dissociation curve shown in Fig. 2. Interpreting the disso-
ciation kinetics according to this scheme, the observed fast
and slow exponential phases of the dissociation curve cor-
respond to the dissociation of complexes {MP*}1 and
{MP*}2, respectively. The microscopic observed rate con-
stants koff,1 and koff,2 are equal to kfast
o and kslow
o , and the
amplitudes of the fast and slow exponential phases in the
dissociation curve faithfully reflect the initial populations of
the two complexes. This is the simplest interpretation of the
observed dissociation data.
Sequential systems
The parallel system is not the only solution consistent with
our data, however. One could also account for the observed
dissociation curve with a “sequential” system in which the
two complexes can slowly interconvert, as shown in
Scheme 2.
MP*1
21%	
L|;
«0.04 h
1
0.04 h
1
MP*2
79%	
1.2 h
1n ,0
M P*
Scheme 2
Here, complex {MP*}2 does not dissociate directly at an
appreciable rate. Rather, it dissociates through the “kinetic
intermediate” {MP*}1. The initial populations of the two
complexes are still close to the magnitudes of the observed
fast and slow dissociation phases, and the microscopic rate
constants koff,1 and k21 are equal to the observed rate con-
stants kfast
o and kslow
o . Scheme 2 also produces the observed
dissociation curve shown in Fig. 2.
Other schemes that are consistent with the observed dis-
sociation curve can be proposed in which the interconver-
sion of the complexes is more rapid. In such systems, the
observed kinetics are distorted from the microscopic rates.
For example, the system shown in Scheme 3 produces the
MP* dissociation curve in Fig. 2, even though the micro-
scopic rate constants do not match the observed rate con-
stants and the initial populations of the two complexes are
far from the magnitudes of the observed fast and slow
dissociation phases.
MP*1
42%	
L|;
0.56 h
1
0.08 h
1
MP*2
58%	
0.60 h
1n ,0
M P*
Scheme 3
The kinetic distortions seen in this sequential scheme can be
understood in terms of a steady-state approximation for the
fast-dissociating complex {MP*}1. In the fast phase of
dissociation, the population of {MP*}1 rapidly drops to its
steady-state level, with a rate constant kfast
o about equal to
koff,1  k12  0.60 h

1  0.56 h
1  1.16 h
1. After
{MP*}1 reaches this level, the steady-state approximation
tells us that the system decays with a rate constant kslow
o of
(k21 koff,1)/(koff,1  k12)  0.041 h

1. These are the values
of kfast
o and kslow
o that are observed in Fig. 2. The steady-state
FIGURE 4 The set of systems that produce the dissociation curve shown
in Fig. 2 lies on a two-dimensional surface in “kinetic space.” The three
axes correspond to the values of the microscopic rate constants k12, k21, and
koff,2; the fourth microscopic rate constant, koff,1, is related to the others by
Eq. 20 (Table 1). The fraction of complex in the form {MP*}1 is indicated
by color. Each point on the surface shown represents an MHC-peptide
system that produces the observed dissociation curve; the points corre-
sponding to Schemes 1–5 are indicated. The dotted line indicates the subset
of this solution space, which is also consistent with the data shown in Fig.
4. The gray dot indicates the system that was used to numerically simulate
the data in Figs. 2 and 4.
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approximation also helps rationalize the observed magni-
tude of the fast dissociation phase. Because the initial pop-
ulation of fast-dissociating {MP*}1 is partitioned over dis-
sociation and interconversion reactions, the initial 42%
population of {MP*}1 gives rise to only an 18% observed
fast phase. It should be recognized that the steady-state
approximation is not a precise treatment of this reaction
scheme. A more detailed analysis, provided in the Appendix
and summarized in Table 1, shows that the relationship
between the observed kinetics and the microscopic rate
constants is in fact much more complicated.
Kinetic partitioning distorts the rate constants and popu-
lations in any MHC-peptide system for which the rate of
conversion of {MP*}1 to {MP*}2 is comparable to the other
reaction rates. This means that, except in the case of the
parallel system, the magnitude of the observed fast phase in
a dissociation reaction underestimates the initial population
of the complex {MP*}1, sometimes to a great degree. Con-
sider the system shown in Scheme 4, which is also consis-
tent with the dissociation curve in Fig. 2.
MP*1
100%	
L|;
0.80 h
1
0.19 h
1
MP*2
0%	
0.25 h
1n ,0
M P*
Scheme 4
In this case, all of the complex is initially present in the
faster-dissociating form {MP*}1, yet the magnitude of the
observed fast dissociation phase is only 18%.
Complete mechanisms
In the examples discussed so far, one or more microscopic
reaction rates are negligible. However, most of the solution
space for our dissociation curve consists of reaction systems
in which all of the microscopic reactions proceed at signif-
icant rates. One example of such a system is shown in
Scheme 5; like the other examples, it too generates the
biphasic dissociation curve in Fig. 2.
MP*1
20%	
L|;
0.060 h
1
0.015 h
1
MP*2
80%	
1.14 h
1n ,0.026 h
1
M P*
Scheme 5
This particular example is interesting because the two com-
plexes are initially at equilibrium: the ratio of the initial
concentrations of {MP*}2 to {MP*}1 is equal to K1º2 
k12/k21  4.
Although there is a diverse range of systems that are
consistent with our observed dissociation curve, we can
place limits on the values of the microscopic parameters of
the actual MHC-peptide system. As shown in Fig. 4, the
microscopic rate constant koff,1 must be less than or equal to
the observed kfast
o (1.2 h
1), and koff,2 must be less than or
equal to kslow
o (0.04 h
1). The rate constants for intercon-
version, k12 and k21, can range from 0 (in the case of the
parallel scheme) to a value less than the observed kfast
o . The
fraction of complex initially in the form {MP*}1 must be
greater than Fo, the observed magnitude of the fast disso-
ciation phase, and can, in principle, be as high as 100%.
For simplicity, the observed magnitudes (Fo and So) and
rate constants (kfast
o and kslow
o ) of biphasic MHC-peptide
dissociation curves in previous reports have often been
taken as readouts of the initial concentrations and dissoci-
ation rate constants of the faster and slower dissociating
complexes (Beeson and McConnell, 1994; Beeson et al.,
1996; Rabinowitz et al., 1997). However, as the above
examples demonstrate, this simple interpretation is valid
only if the complexes interconvert very slowly relative to
the dissociation reactions. Slow interconversion need not be
the case, however. Experiments involving “regeneration” of
a fast dissociation phase from partially dissociated MHC-
peptide complexes show that the interconversion rate of
isomeric complexes can be comparable to or faster than that
of dissociation reactions (Schmitt et al., 1998b). In the
absence of additional information, therefore, it is generally
prudent to consider the full range of consistent systems
when interpreting MHC-peptide dissociation kinetics.
Information from variation of binding time
Although it is generally not possible to determine the initial
concentrations of the two isomeric complexes in a typical
dissociation experiment, one can nevertheless manipulate
these concentrations to some extent by varying the length of
the binding incubation that precedes the dissociation. Be-
cause the two MHC-peptide complexes are almost certainly
formed at different rates, the relative populations of the
complexes should depend on the length of the binding
incubation. Therefore, by changing the binding time, one
can systematically vary the ratio of the complexes’ concen-
trations for different dissociation experiments. This varia-
tion in concentrations shows up indirectly in the observed
magnitude of fast dissociation phase, Fo, over a range of
binding incubation times (Fig. 5).
Measurement of the magnitude of fast dissociation phase
after different binding times provides additional information
about the microscopic kinetics of the system. Fig. 5 A shows
a plot of the observed magnitude of fast dissociation phase,
Fo, for simulated dissociations after binding incubations of
up to 20 h; this curve is an approximately exponential decay
from a maximum of F0
o  0.48 at zero binding time, with a
limiting value of 0.03 at long binding times. The data can
also be plotted as the ratio of the observed slow and fast
dissociation phases, producing the sigmoidal curve shown
in Fig. 5 B. The precise shapes of these curves depend upon
the rate of complex formation, which is limited by the rate
at which MHC becomes available for binding the labeled
peptide through dissociation of endogenous peptide or by
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activation of “dormant” empty MHC (Rabinowitz et al.,
1998). However, the limits of the curves in zero and infinite
binding time do not depend on these ancillary processes.
In the limit of zero binding time, the ratio of the isomeric
complexes formed is entirely determined by the ratio of
their binding rate constants kon,1 and kon,2. If the binding
reaction is carried out under the same conditions of temper-
ature and pH as the dissociation reactions, these binding rate
constants are related to the dissociation and interconversion
rate constants of the complexes through a thermodynamic
cycle:
kon,1
koff,1
k12
k21
koff,2
kon,2
 KMºMP1KMP1ºMP2KMP2ºM 1 (3)
Consequently, the molar fraction of complex in the form
{MP*}1 extrapolated to zero binding time can be expressed
as
XMP*10	
koff,1k21
koff,1k21 k12koff,2
(4)
Because the magnitude of the observed fast dissociation
phase is related to the fraction of {MP*}1 through Eq. 18
(Table 1), measurement of the magnitude of fast dissocia-
tion phase in the limit of zero binding time, F0
o, provides
additional information about the values of the microscopic
rate constants of the MHC-peptide system.
We can calculate the F0
o values that would be observed
for the candidate systems described by Schemes 1–5, using
the rate constants provided. Of the five candidates dis-
cussed, Schemes 2, 4, and 5 are not consistent with the
observed value F0
o  0.48 for the binding variation data in
Fig. 5. In terms of the “kinetic space” of MHC-peptide
systems shown in Fig. 4, our measurement of F0
o restricts the
range of possible candidates to the one-dimensional slice
indicated by the dotted line.
FIGURE 5 The magnitude of observed fast phase, Fo, after binding
incubations of 0.2, 0.5, 1, 2, 4, 8, 13, and 20 h for two simulations of a
two-complex reaction system with the same observed dissociation rate
constants as in Fig. 2. The simulations used the rate constants given in
Experimental Techniques, with an initial peptide concentration of 100 M
and 1 MMHC protein initially in the form {MPe} (E) or MI (). (A) The
value of Fo is greatest after short binding incubations and decreases for
longer binding incubations. (B) The ratio of the observed slow and fast
dissociation phases as a function of binding time. Note that the precise
shapes of these curves depend upon reactions that precede complex for-
mation, but the values extrapolated to binding times of 0 and infinity (1.074
and 32.4) are in the same ratio as the observed rate constants (kfast
o /kslow
o 
30) and are independent of the binding process. (C) A close-up of the curve
from B, showing the ratio of the slow to the fast dissociation phase after
short incubation times for the two simulations. The solid line illustrates the
limiting value of the slope of this curve, as calculated from the kinetic
model. The So/Fo ratio extrapolated to zero binding time is 1.074, corre-
sponding to a magnitude of the fast phase F0
o  0.482.
TABLE 1 Relationships between the observed and
microscopic kinetic parameters of a two-complex
MHC-peptide system
kfast
o 
k k2 4k	1/2
2
(16)
kslow
o 
k k2 4k	1/2
2
(17)
Fo
koff,1 koff,2	XMP*1 koff,2 kslow
o 	
kfast
o  kslow
o (18)
So
koff,1 koff,2	XMP*2 kfast
o  koff,1	
kfast
o  kslow
o (19)
with sum and product terms:
k kfast
o  kslow
o  koff,1 k12 k21 koff,2 (20)
k kfast
o kslow
o  koff,1k21 koff,1koff,2 k12koff,2 (21)
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Solving the equations in Table 1 for the parallel and
sequential mechanisms gives general expressions for the
limits of the microscopic parameters that are consistent with
MHC-peptide dissociation experiments; these are shown in
Table 2. Systems involving interconversion as well as direct
dissociation of both complexes are characterized by values
falling between the two extremes.
Like the magnitude of the fast dissociation phase at zero
binding time, the value of Fo after infinite binding time is
determined entirely by the system’s microscopic intercon-
version and dissociation rate constants. In the limit of infi-
nite binding time, the two isomeric MHC-peptide com-
plexes are in equilibrium with each other; hence their
populations are in the ratio of k12/k21, and the fraction of
complex in the form {MP*}1 is
XMP*1eq	
k12
k12 k21
(5)
The magnitude of the fast dissociation phase after binding to
equilibrium is related to this fraction of {MP*}1 and is
therefore also characteristic of the MHC-peptide system.
Interestingly, the magnitudes of the fast and slow expo-
nential phases at zero and infinite binding time are related to
one another in a fairly simple way. It can be shown that the
kinetic equations in Table 1 lead to the relationship
SoFo
eq

kfast
o
kslow
o SoFo
0
(6)
where So is the normalized magnitude of the slow phase.
Because of this, it is useful to determine the value of Fo at
both zero and infinite time as a check on the two-complex
model. In a sigmoidal plot of slow/fast phase versus binding
time, the extrapolated values at zero and infinity should be
in the same ratio as the slow and fast observed dissociation
rate constants.
Another useful feature of the So/Fo curve is illustrated in
Fig. 5 C. At short incubation times, it can be shown that the
curve approaches the line y  y0  (1/2)y0(kfast
o 
 kslow
o )t.
This allows one to estimate the value of the So/Fo ratio—and
therefore the value of Fo—at zero time from the value at a
binding time t close to zero, using the formula
SoFo
0
  22 kfasto  kslowo 	tS
o
Fo
t
(7)
It is important to note that the foregoing discussion is
valid only if the binding conditions used to prepare the
MHC-peptide complex are identical to the conditions of the
dissociation reactions (except for peptide concentration). If
binding and dissociation are performed under different con-
ditions, the magnitude of the fast dissociation phase will
depend on the microscopic rate constants under both sets of
conditions, which greatly complicates the analysis of disso-
ciation behavior for various binding times.
Even after dissociation is measured following a range of
binding times, there is still a continuum of candidate sys-
tems that are consistent with the kinetic data, indicated by
the dotted line in Fig. 4. To determine where our system lies
along this line, we need measurements of the concentrations
of the two complexes; the indirect readout provided by the
magnitude of observed dissociation fast phase is not suffi-
cient. Conventional kinetic measurements of MHC-peptide
dissociation do not distinguish between different isomeric
forms of the MHC-peptide complex, but other techniques
may be used to detect and measure the two complexes. For
example, 19F NMR has been used to directly measure the
relative populations of different complexes in several MHC-
peptide systems (Schmitt et al., 1998a).
Consider the example of the peptide PCC, consisting of
residues 89–104 of pigeon cytochrome c, bound to the class
II MHC molecule I-Ek. Kinetic studies (Schmitt et al.,
1998b) have shown that this system shows distinctly bipha-
sic dissociation kinetics at pH 5.3 and 25°C, with observed
rate constants of kfast
o  1.70 
0.29/0.44 h
1 and kslow
o 
0.01397 
0.00006/0.00006 h
1. From the reported dis-
sociation results following different binding times, we can
estimate the ratio of the slow to the fast phase at zero
binding time as (Fo/So)0  2.72 
0.40/0.47, correspond-
ing to a fast phase at zero binding time of F0
o  0.27

0.03/0.03. Separate NMR measurements (Schmitt et al.,
1998a) have shown that when the complexes are isolated at
pH 7.0 and 25°C, the fraction of complex in the form
{MP*}1 is X{MP*}1  0.5 
0.045/0.045, and the magni-
tude of the fast phase in a subsequent dissociation at pH 5.3
and 25°C is Fo(X1  0.5)  0.141 
0.013/0.013. Using
these values, Eq. 4, and the equations in Table 1, we
calculate that the microscopic rate constants of this system
are koff,1  0.50 
0.15/0.25 h

1; k12  1.17 
0.28/
0.40 h
1; k21  0.043 
0.027/0.068 h

1; koff,2 
0.0013 
0.0013/0.0072 h
1. Based on these calculated
rate constants, the equilibrium fraction of {MP*}1 at pH 5.3
is X{MP*}1(eq)  0.036 
0.026/0.078; this is very differ-
ent from the value (0.5) measured at pH 7.0. This example
shows that some of the microscopic parameters, namely k21
and koff,2, are difficult to determine precisely; nevertheless
TABLE 2 Limits on the microscopic parameters consistent
with observed dissociation curves
Parameter Parallel mechanism
Sequential
mechanism
koff,1 kfast
o F0
o kfast
o  S0
o kslow
o
k12 0
F0
o S0
okfast
o  kslow
o 	2
F0
o kfast
o  S0
o kslow
o
k21 0
kfast
o kslow
o
F0
o kfast
o  S0
o kslow
o
koff,2 kslow
o 0
For a given dissociation curve:
X{MP*}1 F
o Fokfast
o  Sokslow
o
F0
o kfast
o  S0
o kslow
o
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the calculated ranges do provide useful information about
the system.
Hidden biphasic kinetics
Observation of a biphasic dissociation curve proves that
isomeric forms of the MHC-peptide complex are present,
even though they may not be detected directly. The inverse
of this statement is not true, however. That is, the absence
of an observed fast dissociation phase does not rule out the
presence of multiple complexes. Indeed, if the dynamics of
the MHC-peptide complexes are dominated by interconver-
sion rather than dissociation, it can be virtually impossible
to observe a biphasic dissociation curve, even though two
different complexes are initially present.
For complexes prepared under the same conditions as the
dissociation measurement, the maximum magnitude of ob-
servable fast phase is F0
o, as can be seen in Fig. 5. From Eq.
18, we can derive an upper limit for F0
o in terms of the
interconversion rate of the complexes. For a relative inter-
conversion rate of
ki
k12 k21	
koff,1 koff,2	
(8)
the value of F0
o cannot be greater than 1/(1  ki), and
generally will be less than this, especially if the complex
{MP*}2 has a significant dissociation rate. For example, if
two MHC-peptide complexes have dissociation rate con-
stants of 0.09 h
1 and 0.01 h
1 and interconversion rate
constants of 6 h
1 and 4 h
1 (Scheme 5), then ki 100, and
so F0
o must be less than 0.01.
MP*1
86%	
L|;
6 h
1
4 h
1
MP*2
14%	
0.09 h
1n ,0.01 h
1
M P*
Scheme 6
Simulation of this system shows that the observed dissoci-
ation rate constants are 10.1 h
1 and 0.042 h
1, but the
value of F0
o is only 0.0037 (Fig. 6, circles). This fast phase,
with magnitude less than 0.4%, is impossible to detect using
current methods.
Can systems with such rapid interconversion rates be
physiologically relevant? In the example described above,
the two complexes have characteristic lifetimes with respect
to dissociation (off  1/koff) of 11 h and 100 h. By com-
parison, their lifetimes with respect to interconversion are
10 min and 15 min. Although the interconversion reactions
are much more rapid than dissociation, interconversion is
still slow enough to keep the two complexes distinct from a
physiological point of view, even though they are not ki-
netically resolvable. In a physiological context, the impor-
tant time scale is the lifetime of the ternary MHC-peptide/
TCR complex, which is on the order of seconds (Matsui et
al., 1991, 1994).
Significantly, the magnitude of a fast dissociation phase
may be undetectably small, even though the system initially
contains a large fraction of {MP*}1. In the example shown
in Scheme 6, the fraction of complex {MP*}1 present after
a very short binding incubation is 85.7%; nevertheless, only
a 0.4% fast phase is observed. The relatively fast intercon-
version renders the fast-dissociating complex “kinetically
invisible” in dissociation experiments.
Another way in which a fast-dissociating MHC-peptide
complex can evade kinetic detection is to have similar rate
constants for the observed fast and slow dissociation phases.
If the rate of interconversion is comparable to the rate of
dissociation and the equilibrium constant between the two
complexes favors the faster-dissociating {MP*}1, then the
two observed rate constants can be very similar. Consider
the system shown in Scheme 7:
MP*1
99.6%	
L|;
0.004 h
1
0.1 h
1
MP*2
0.4%	
0.09 h
1n ,0.01 h
1
M P*
Scheme 7
Here the microscopic dissociation rate constants are the
same as in Scheme 6, but the relative rate of interconver-
sion, ki, is only (0.004 h

1  0.1 h
1)/(0.09 h
1  0.01
h
1)  1.04. Even though the maximum magnitude of the
fast dissociation phase for this system is a relatively high
30.4%, the observed rate constants of this system, 0.124 h
1
and 0.0805 h
1, differ by only a factor of 1.5 (Fig. 6,
squares). A double-exponential dissociation curve with
such similar rate constants is virtually impossible to distin-
guish from a single-exponential curve, given the noise in
current experiments (on the order of 1%). In general, two-
complex systems like this one, with small equilibrium con-
stants of interconversion (Ki  k12/k21), will have similar
observed dissociation rate constants.
FIGURE 6 “Hidden” biphasic kinetics in MHC-peptide dissociation re-
actions: dissociation curves for the systems described by Schemes 6 (E)
and 7 (), after a very short binding incubation to maximize the amount of
fast phase observed. The solid lines are single-exponential curve fits to the
data.
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The examples of Schemes 6 and 7 illustrate that biphasic
dissociation kinetics of a two-complex system can be diffi-
cult to resolve if either ki or 1/Ki is greater than 1. Many
two-complex systems may fall into one or both of the
“unresolvable” categories illustrated by these schemes. This
suggests the possibility that isomeric MHC-peptide com-
plexes may be much more common than previously believed.
Although biphasic kinetics of an MHC-peptide system
may be unresolvable under typical dissociation conditions,
other conditions may produce more clearly biphasic behav-
ior. MHC-peptide dissociation reactions are intrinsically
relaxation processes, in which a sample prepared in the
presence of labeled peptide is perturbed by removing un-
bound peptide and/or adding an excess of unlabeled com-
petitor peptide. But other conditions, such as temperature
and pH, can also be changed when dissociation is initiated.
For example, a bound MHC-peptide complex may be stored
at a low temperature (4°C) and then warmed to carry out a
dissociation experiment at 25°C or 37°C. Alternatively,
samples may be prepared at pH 5.3 for dissociations carried
out at pH 7.0.
As discussed earlier, if the MHC-peptide complex is
prepared under the same conditions as the dissociation
reaction, the maximum magnitude of the dissociation fast
phase is observed in the limit of zero binding time; this is
also shown in Fig. 7 A. However, if the conditions are not
the same, it may be possible to prepare the system such that
the initial fraction of fast-dissociating {MP*}1—and hence
the observed fast dissociation phase—is enhanced. This
enhancement may permit the resolution of biphasic behav-
ior for some systems. Fig. 7 A also shows that an interesting
situation can result when the complex is prepared so that the
initial fraction of {MP*}1 is very small. If the amount of
{MP*}1 is small enough, the magnitude of observed fast
dissociation can be zero or even negative! Such a dissoci-
ation appears to have a “lag period” at early time points
(Fig. 7 B).
Another useful perturbation of the MHC-peptide system
involves the addition of other chemical species to the reac-
tion system. Dimethyl sulfoxide has been demonstrated to
enhance peptide release from MHC (Schmitt et al., 1998a),
as has the peptide dynorphin A (1–13) (de Kroon and
McConnell, 1993; Schmitt, 1999). The chaperone molecule
DM also catalyzes peptide release from MHC (Denzin and
Cresswell, 1995). These substances appear to act dispropor-
tionately on the fast-dissociating isomer of the MHC-pep-
tide complex, and as such may provide an aid in resolving
two-complex dissociation kinetics.
CONCLUSIONS
Technical obstacles to measuring MHC-peptide reaction
kinetics have largely been overcome (Witt and McConnell,
1993), but it is clear that such studies by themselves provide
limited information about the isomers’ dynamics. Although
existing kinetic measurements cannot provide complete in-
formation about the reactions between MHC and peptides,
the application of different techniques for characterizing
MHC-peptide complexes and kinetics can help to focus the
picture of these interactions.
This analysis also offers the prospect of resolving the
mechanistic effects observed in changes in temperature
(Witt and McConnell, 1994), pH (Witt and McConnell,
1991; Boniface et al., 1993; Schmitt et al., 1998b), and
peptide sequence (Dornmair et al., 1991; Beeson et al.,
1996; Liang et al., 1996; Schmitt et al., 1998b), which may
be relevant to the biological function of these multiple-
isomer MHC-peptide complexes. A further objective of this
FIGURE 7 The magnitude of the observed dissociation fast phase gen-
erally does not reflect the initial amount of fast-dissociating complex. (A)
The relationship between the magnitude of the observed fast phase, Fo, and
the initial fraction of the fast-dissociating complex {MP*}1 is linear and
depends on the interconversion and dissociation rates of the two com-
plexes. For a given set of observed dissociations, consistent mechanisms
span the range from parallel (e.g., Scheme 1), indicated by the heavy line
labeled par, to sequential (e.g., Scheme 3), indicated by line seq. A dashed
line (— - —) corresponds to the actual mechanism used for the simulation
of Figs. 2 and 4. The observed fast dissociation phases in the limits of zero
and infinite binding time are indicated by the vertical dotted lines. (B) A
dissociation curve with a negative fast phase. Shown is a simulated
dissociation curve for the two-complex system described in Scheme 3,
starting from an initial population of 0.8% {MP*}1 and 99.2% {MP*}2; for
this curve, Fo  
0.034. Inset: The early portion of the dissociation curve
deviates from a single-exponential curve (dotted line).
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work is to extend our analysis to the binding reactions of
peptides to MHC molecules. These reactions, which have
obvious importance in the understanding of MHC-peptide
interactions, have been demonstrated to show complicated
kinetics (Tampe´ and McConnell, 1991; Witt and McCon-
nell, 1991, 1992; de Kroon and McConnell, 1993; Mason
and McConnell, 1994; Rabinowitz et al., 1998; Natarajan et
al., 1999) and are not merely the “reverse” of the dissocia-
tion reactions.
Finally, we hope to use this work to guide single-mole-
cule fluorescence studies of MHC-peptide systems. Struc-
tural differences between isomeric complexes may influ-
ence environment-sensitive fluorescent labels. Any
difference in fluorescence between complexes could be
exploited in single-molecule studies, for which the amount
of fluorescence would provide a direct measure of the state
of the bound peptide. Intensity correlation functions may
also permit the determination of isomerization rates (Wen-
nman et al., 1997). Single molecule techniques are dis-
cussed in a recent issue of Science (Gimzewski and
Joachim, 1999; Mehta et al., 1999; Moerner and Orrit, 1999;
Weiss, 1999).
APPENDIX: ANALYTICAL SOLUTION OF THE
RATE EQUATIONS
In general, for a system of N chemical species interacting by first-order
(A3 B) reactions, the time-dependent concentrations of the species can be
described by an (N 
 1)-exponential curve plus a constant equilibrium
value (Moore and Pearson, 1981). For the irreversible dissociation of
isomeric MHC-peptide complexes shown in Fig. 1 B, N  3 (complexes
{MP*}1 and {MP*}2, and the dissociated state), and the equilibrium
concentrations of the complexes are zero. Hence the total concentration of
the two complexes during an irreversible dissociation reaction can be
described by a biexponential curve.
Expressions for the macroscopic rate constants kfast
o and kslow
o of this
biexponential curve can be found by integrating the rate equations for the
reactions shown in Fig. 1 B. The concentrations of the three MHC species
are described by the differential equations
dMP*1
dt

koff,1 k12	MP*1 k21MP*2 (9)
dMP*2
dt
 k12MP*1 k21 koff,2	MP*2 (10)
dM
dt
 koff,1MP*1 koff,2MP*2 (11)
Solving this system of differential equations gives the expressions for the
macroscopic rate constants kfast
o and kslow
o shown in Table 1, as well as
expressions for the coefficients Fo and So.
The observed magnitudes of fast and slow phase, Fo and So, correspond
to the sums of the two complexes’ fast and slow coefficients. Expressions
for these magnitudes can also be derived by examining the total dissocia-
tion rate of the complexes in terms of the concentrations and rate constants
involved. From the mechanism in Fig. 1 B, we can express the initial rate
of the dissociation reaction of an MHC-peptide system as


dMP*
dt
0	 MP*1koff,1 MP*2koff,2 (12)
Normalized with respect to the total initial concentration of the MHC-
peptide complex, this becomes


dMP*
dt
0	 XMP*1koff,1 XMP*2koff,2 (13)
where X{MP*}1 and X{MP*}2 are the initial fractions of the two complexes.
A similar rate equation can be written based on the empirical biphasic
concentration curve (Eq. 2) that is fit to the dissociation data. Differenti-
ating this (already normalized) function with respect to time gives the
initial dissociation rate as


dMP*
dt
0	 Fokfast
o  Sokslow
o (14)
Combining Eqs. 13 and 14 gives the relation
XMP*1koff,1 XMP*2koff,2 F
okfast
o  Sokslow
o (15)
Given that X{MP*}1  X{MP*}2  1 and F
o  So  1, Eq. 15 can be
rearranged to give the expressions for Fo and So shown in Table 1.
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